Linq II
Payments companies reported to CMS as associated with Linq II. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Linq II, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Linq II
These are the largest totals companies reported as associated with Linq II. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Rogers | La Jolla, CA | Clinical Cardiac Electrophysiology | $12,537.50 |
| Poulina Uddin | San Diego, CA | Cardiovascular Disease | $8,669.01 |
| Beth Loessin | Columbus, OH | Family | $7,031.41 |
| Erik Altman | Garden City, NY | Clinical Cardiac Electrophysiology | $5,684.76 |
| Eugene Fu | Columbus, OH | Clinical Cardiac Electrophysiology | $4,869.11 |
| Bharath Reddy | Brooklyn, NY | Clinical Cardiac Electrophysiology | $4,782.48 |
| Damian Rasch | Encinitas, CA | Cardiovascular Disease | $3,718.40 |
| Sameer Parekh | Garden City, NY | Clinical Cardiac Electrophysiology | $3,676.51 |
| Nadine Wlasiuk | San Francisco, CA | Family | $3,646.53 |
| Amanda Breuer | Madison, WI | Medical | $3,469.29 |
Prescribed Linq II?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.